“…Besides its function as a substrate for glucosyltransferases resulting in glucosylated surface structures, UDP-glucose plays a well-established biochemical role as a glycosyl donor in the enzymic biosynthesis of carbohydrates (Csonka & Epstein, 1996;Stimson et al, 1995). The galU gene was found to be important for pathogenesis of infections due to a number of Gram-negative pathogens, including Actinobacillus pleuropneumoniae (Rioux et al, 1999), Escherichia coli (Komeda et al, 1977), Klebsiella pneumoniae (Chang et al, 1996), Pseudomonas aeruginosa (Evans et al, 2002;Priebe et al, 2004), Shigella flexneri (Sandlin et al, 1995) and Vibrio cholerae (Nesper et al, 2001). The phenotypes of the K. pneumoniae and V. cholerae galU mutants were dominated by abnormal capsule synthesis rather than LPS O-antigen abnormalities, and several of the galU mutants also had defects in other surface proteins, such as IscA for S. flexneri (Sandlin et al 1995) and flagella for E. coli (Komeda et al, 1977).…”